news Novel strategy successfully suppresses HIV infection in mice 25 October 2021 | By Anna Begley (Drug Target Review) A new method, called synapse for T-cell activation (synTac), can attack HIV-infected T cells and may be a new cure for HIV and other diseases.
news Experimental drug shown to reverse effects of Alzheimer’s in mice 23 April 2021 | By Victoria Rees (Drug Target Review) Oral doses of a new drug named CA administered to mouse models led to improvements in Alzheimer's disease, including memory.
news Team reveals why children’s immune response to COVID-19 is better than adults’ 24 September 2020 | By Victoria Rees (Drug Target Review) Researchers have identified two molecules that explain why children experience COVID-19 differently to adults.
article Why invest in creating a modifiable drug framework? 27 February 2020 | By Hannah Balfour (Drug Target Review) Drug Target Review spoke with CUE Biopharma’s President and CSO to find out how and why they created the ImmunoSTAT platform and the ways it may benefit drug design in the future.
news IL1RAP protein boosts multiple oncogenic pathways in AML 18 May 2018 | By Dr Zara Kassam (Drug Target Review) Researchers have discovered that a signalling protein elevated in patients with AML plays a much wider role in the disease than previously thought...
news CXCR7 receptor reveals potential therapeutic target to reduce brain inflammation 6 November 2017 | By Dr Zara Kassam (Drug Target Review) CXCR7 receptor identified as a potential therapeutic target for controlling multiple sclerosis, Parkinson's and AIDS...
news BTSA1 causes cancer to self-destruct without affecting healthy cells 10 October 2017 | By Dr Zara Kassam (Drug Target Review) Scientists have discovered a compound that causes cancer cells to self-destruct while sparing healthy cells...